Anzeige
Mehr »
Login
Samstag, 21.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EJLK | ISIN: US42328V8019 | Ticker-Symbol: 26H
NASDAQ
20.12.24
21:59 Uhr
0,860 US-Dollar
+0,408
+90,27 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HELIUS MEDICAL TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
HELIUS MEDICAL TECHNOLOGIES INC 5-Tage-Chart

Aktuelle News zur HELIUS MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.11.Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS) Device4
18.11.Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives112NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation...
► Artikel lesen
18.11.HELIUS MEDICAL TECHNOLOGIES, INC. - 8-K, Current Report2
12.11.HELIUS MEDICAL TECHNOLOGIES, INC. - 10-Q, Quarterly Report-
14.10.Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece7
08.10.Helius Medical stock hits 52-week low at $0.5 amid sharp decline4
30.09.Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study97-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment at week 14 -- -- Confirms the...
► Artikel lesen
16.08.Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)192NEWTOWN, Pa., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced...
► Artikel lesen
HELIUS MEDICAL Aktie jetzt für 0€ handeln
12.08.HELIUS MEDICAL TECHNOLOGIES, INC. - 10-Q, Quarterly Report1
12.08.Helius Medical Technologies GAAP EPS of -$0.64 misses by $0.14, revenue of $0.18M beats by $0.03M1
12.08.Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results206NEWTOWN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation...
► Artikel lesen
10.08.Helius Medical faces Nasdaq delisting over share price1
09.08.HELIUS MEDICAL TECHNOLOGIES, INC. - 8-K, Current Report1
06.08.Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 20242
24.07.HELIUS MEDICAL TECHNOLOGIES, INC. - S-8, Securities to be offered to employees in employee benefit plans1
28.06.HELIUS MEDICAL TECHNOLOGIES, INC. - 8-K, Current Report1
31.05.Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference608NEWTOWN, PA / ACCESSWIRE / May 31, 2024 / Helius Medical Technologies, Inc., (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation...
► Artikel lesen
03.05.Pre-market Movers: Helius Medical Technologies, AEON Biopharma, Sprout Social, El Pollo Loco, Terran Orbital713THOUSAND OAKS (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.05 A.M. ET).In the Green Helius Medical Technologies, Inc. (HSDT) is...
► Artikel lesen
28.03.Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results165-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused...
► Artikel lesen
04.03.Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS) Mouthpiece and Controller188-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis ("MS") -- -- Proceeds from recent stock issuances...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1